27, 2025 — Scientists have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia ... Novel Bone Marrow Transplant Can ...

The 3-year overall survival rates for each group were 83.1% for the MSD-ASCT group, 85.7% for the auto-HSCT group, and 70.4% for the chemotherapy group. For patients with acute myeloid leukemia ...

Results showed that the antibodies neutralized AML and prolonged survival in four separate mouse models of leukemia. Notably, the antibodies effectively targeted leukemic stem cells in bone ...

AB Science SA (Euronext - FR0010557264 - AB) announces today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the ...

In four separate mouse models of leukemia, the antibodies neutralized AML and prolonged survival, with no apparent toxicity. Most excitingly, the antibodies effectively targeted leukemic stem ...

In support of the significant benefit of AB8939 in AML, AB Science has released preclinical data from mouse models demonstrating a significant benefit of AB8939 treatment over current therapies, such ...

About two minutes into the school year, he became ill and was diagnosed with Acute B-Cell Leukemia. "I caught a fever and I was sick and we just thought it was a regular fever and it would blow over.

Researchers recently calculated the estimated savings over a 30-year period with regard to CML patients who attempt to get off their TKI therapy. In what they referred to as a 'conservative ...

I take a holistic approach. I think we need to make physicians who treat chronic myeloid leukemia treat the disease and make them more aware that you need to go beyond just looking at numbers.”— ...